Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2009 1
2012 1
2013 1
2014 1
2015 1
2016 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
Shiffman ML, Rustgi V, Bennett M, Forns X, Asselah T, Planas Vila R, Liu L, Pedrosa M, Moller J, Reau N. Shiffman ML, et al. Among authors: planas vila r. Am J Gastroenterol. 2016 Jun;111(6):845-51. doi: 10.1038/ajg.2016.108. Epub 2016 Apr 5. Am J Gastroenterol. 2016. PMID: 27045929 Free PMC article.
Hepatitis B virus reactivation after cessation of prophylaxis with entecavir in a patient with Burkitt type acute lymphoblastic leukaemia treated with rituximab.
Juan Juan A, Caballero de García N, Masnou Ridaura H, Sala Llinas M, Morillas MR, Planas Vila R. Juan Juan A, et al. Among authors: planas vila r. Gastroenterol Hepatol. 2017 Aug-Sep;40(7):470-471. doi: 10.1016/j.gastrohep.2016.08.005. Epub 2016 Oct 13. Gastroenterol Hepatol. 2017. PMID: 27743784 English, Spanish. No abstract available.
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study Group. Poynard T, et al. Gastroenterology. 2009 May;136(5):1618-28.e2. doi: 10.1053/j.gastro.2009.01.039. Epub 2009 Jan 22. Gastroenterology. 2009. PMID: 19208349 Clinical Trial.
[Prognostic factors associated with mortality in patients with severe alcoholic hepatitis].
Bargalló García A, Serra Matamala I, Marin Fernández I, Masnou Ridaura H, Leal Valdivieso C, Marcos Neira P, Sala Llinars M, Morillas Cunill R, Planas Vila R. Bargalló García A, et al. Among authors: planas vila r. Rev Esp Enferm Dig. 2013 Oct;105(9):513-20. doi: 10.4321/s1130-01082013000900002. Rev Esp Enferm Dig. 2013. PMID: 24467495 Free article. Spanish.
Drug eruptions induced by telaprevir in patients with chronic hepatitis C virus genotype 1 infection: a prospective study.
Toro Montecinos M, Carrascosa Carrillo JM, Vilavella Rius M, Bielsa Marsol I, Plana Pla A, Morillas Cunill R, Planas Vilà R, Masnou Ridaura H, López Escartin D, Ferrándiz Foraster C. Toro Montecinos M, et al. Among authors: planas vila r. Actas Dermosifiliogr. 2015 Apr;106(3):219-25. doi: 10.1016/j.ad.2014.07.004. Epub 2014 Oct 26. Actas Dermosifiliogr. 2015. PMID: 25444579 Free article. English, Spanish.